Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease

Lancet. 1983 Apr 30;1(8331):987-8. doi: 10.1016/s0140-6736(83)92108-6.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy*
  • Clinical Trials as Topic
  • Dementia / drug therapy*
  • Double-Blind Method
  • Humans
  • Middle Aged
  • Phosphatidylcholines / administration & dosage*
  • Phosphatidylcholines / therapeutic use

Substances

  • Phosphatidylcholines